STOCK TITAN

electroCore to Participate at 35th Annual Roth Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

electroCore, a bioelectronic medicine company, announced participation in the 35th Annual Roth Conference in Dana Point, California from March 12-14, 2023. Chief Strategy Officer, Joshua Lev, will engage in a fireside chat on March 14, 2023, at 1:00 PM PT. The company will hold one-on-one meetings during the event, aimed at expanding its audience and discussing its non-invasive vagus nerve stimulation technology. This strategy is part of electroCore's commitment to enhancing health solutions through innovative nVNS technology for health management and general well-being. Interested parties can schedule meetings via the conference page or contact Investor Relations.

Positive
  • None.
Negative
  • None.

ROCKAWAY, NJ, March 09, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR) a commercial-stage bioelectronic medicine and wellness company, today announced that electroCore’s Chief Strategy Officer, Joshua Lev, will participate in a fireside chat at the 35th Annual Roth Conference in Dana Point, California during March 12-14, 2023.

Roth Conference
Date: Tuesday, March 14, 2023
Time: 1:00 PM PT
Event: Fireside Chat

electroCore will also be available for one-on-one meetings during the conference. For more information or to schedule a meeting, please visit the conference page here or email Investor Relations at ecor@cg.capital.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.

For more information, visit www.electrocore.com.

Investors:
Rich Cockrell
CG Capital
404-736-3838
ecor@cg.capital


FAQ

What is electroCore's participation in the Roth Conference 2023?

electroCore will participate in the Roth Conference from March 12-14, 2023, with a fireside chat by Chief Strategy Officer Joshua Lev on March 14 at 1:00 PM PT.

When is Joshua Lev speaking at the Roth Conference?

Joshua Lev will speak during the fireside chat on March 14, 2023, at 1:00 PM PT.

How can I meet with electroCore representatives at the Roth Conference?

To schedule a one-on-one meeting with electroCore at the Roth Conference, visit the conference page or email Investor Relations.

What technology does electroCore focus on?

electroCore focuses on non-invasive vagus nerve stimulation (nVNS) technology for health management and wellness.

What are the key dates for the Roth Conference 2023?

The Roth Conference will be held from March 12-14, 2023.

electroCore, Inc.

NASDAQ:ECOR

ECOR Rankings

ECOR Latest News

ECOR Stock Data

106.58M
4.91M
25.02%
16.11%
0.67%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
ROCKAWAY